Ultrasound Evaluation of Blind Dry Needling in Lateral Epicondylitis
Launched by NURMUHAMMET TAS · Jun 20, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called dry needling for people with lateral epicondylitis, which is a type of pain on the outer part of the elbow often called “tennis elbow.” The study aims to see how accurate and consistent the dry needling procedure is when done without looking, by comparing it to a guided technique using ultrasound (a kind of imaging that lets doctors see inside the body). This helps the researchers understand if the blind needling method is done correctly and targets the right spots in the muscles.
People who might join this study are adults aged 18 to 70 who have had elbow pain for at least six weeks and have specific tender areas, called trigger points, in the muscles of their forearm. If you join, a doctor will examine your arm to find these trigger points. The study is still not recruiting participants yet, but if you take part, you can expect the dry needling procedure to be done while the researchers check its accuracy with ultrasound. Your participation will help improve how this treatment is performed and could lead to better care for people with this kind of elbow pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteers aged 18-70 years,
- • who have pain in the lateral epicondyle region for at least 6 weeks
- • who have active trigger points in the forearm extensor muscles detected by physical examination
- Exclusion Criteria:
- • Those who have not complained of pain in the lateral epicondyle region for at least 6 weeks
About Nurmuhammet Tas
Nurmuhammet Tas is a clinical trial sponsor engaged in advancing medical research through the design, funding, and oversight of clinical studies. Committed to scientific rigor and patient safety, the sponsor facilitates the development of innovative therapies and contributes to the generation of high-quality clinical evidence aimed at improving healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported